- Stocks
- Healthcare
- NASDAQ: INCY

Price (delayed)

$90.49

Market cap

$19.79B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.89

Enterprise value

$18.51B

INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year

Incyte's revenue has increased by 19% YoY and by 7% from the previous quarter

INCY's net income has dropped by 162% year-on-year but it is up by 49% since the previous quarter

INCY's EPS has shrunk by 162% YoY but it is up by 49% QoQ

The debt is up by 2.8% year-on-year

What are the main financial stats of INCY

Market
Valuations
Earnings

Shares outstanding

218.7M

Market cap

$19.79B

Enterprise value

$18.51B

Price to earnings (P/E)

N/A

Price to book (P/B)

8.39

Price to sales (P/S)

8.25

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

7.75

Revenue

$2.39B

EBIT

-$120.38M

EBITDA

-$67.48M

Free cash flow

-$107.63M

Per share
Balance sheet
Liquidity

EPS

-$0.89

Free cash flow per share

-$0.49

Book value per share

$10.79

Revenue per share

$10.97

TBVPS

$13.21

Total assets

$3.21B

Total liabilities

$867.72M

Debt

$51.69M

Equity

$2.34B

Working capital

$1.52B

Debt to equity

0.02

Current ratio

3.73

Quick ratio

3.62

Net debt/EBITDA

18.93

Margins
Efficiency
Dividend

EBITDA margin

-2.8%

Gross margin

94.9%

Net margin

-8%

Operating margin

-7.7%

Return on assets

-6.1%

Return on equity

-8.2%

Return on invested capital

-13.8%

Return on capital employed

-4.5%

Return on sales

-5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Incyte stock price performed over time

How have Incyte's revenue and profit performed over time

Revenue

$2.39B

Gross profit

$2.26B

Operating income

-$184.82M

Net income

-$191.07M

Gross margin

94.9%

Net margin

-8%

INCY's net income has dropped by 162% year-on-year but it is up by 49% since the previous quarter

Incyte's operating income has plunged by 159% YoY but it has increased by 42% from the previous quarter

The net margin has dropped by 153% year-on-year but it has soared by 53% since the previous quarter

INCY's operating margin has dropped by 150% year-on-year but it is up by 46% since the previous quarter

What is Incyte's growth rate over time

What is Incyte stock price valuation

P/E

N/A

P/B

8.39

P/S

8.25

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

7.75

INCY's EPS has shrunk by 162% YoY but it is up by 49% QoQ

The stock's price to book (P/B) is 67% less than its 5-year quarterly average of 25.3 but 6% more than its last 4 quarters average of 7.9

INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year

INCY's P/S is 37% below its 5-year quarterly average of 13.1

Incyte's revenue has increased by 19% YoY and by 7% from the previous quarter

How efficient is Incyte business performance

INCY's return on assets has dropped by 154% year-on-year but it has surged by 50% since the previous quarter

The ROE has plunged by 154% YoY but it has grown by 50% from the previous quarter

The ROIC has plunged by 132% YoY but it has soared by 64% from the previous quarter

INCY's ROS has shrunk by 132% YoY but it has soared by 65% QoQ

What is INCY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for INCY.

How did Incyte financials performed over time

The company's quick ratio fell by 34% YoY but it rose by 10% QoQ

The current ratio has contracted by 34% YoY but it has grown by 9% from the previous quarter

The debt is 98% smaller than the equity

INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.